Micro Emerging Active

KOD action en hausse : résultats de la rétinopathie diabétique

New narrative with limited coverage — still forming.

Score
0,5
Vélocité
▲ 1,0
Articles
2
Sources
1

Sentiment Timeline

Event Timeline

Avr 12, 2026
Kodiak Sciences (KOD) Reports Q4 EPS of ($1.05) Neutral
Mar 28, 2026
Kodiak Sciences (KOD) Climbs 75% on Stellar Clinical Results Neutral

Chronologie

Première observationMar 28, 2026
Dernière mise à jourMar 28, 2026